58 Projects For Eureka

MADRID—Ministers from 19 European countries have agreed to fund 58 new projects as part of the ongoing Eureka program in advanced technologies. The latest grants, worth a total of 709 million ECU ($800 million), bring to 165 the number of research projects approved since the program was begun in 1985. Meeting here last month, the science ministers also agreed on the possibility of participation by countries from Eastern Europe and North America. The list of participants has grown beyon

Written byMagdalena Ruiz De Elvira
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

MADRID—Ministers from 19 European countries have agreed to fund 58 new projects as part of the ongoing Eureka program in advanced technologies. The latest grants, worth a total of 709 million ECU ($800 million), bring to 165 the number of research projects approved since the program was begun in 1985.

Meeting here last month, the science ministers also agreed on the possibility of participation by countries from Eastern Europe and North America. The list of participants has grown beyond the members of the European Economic Community, and there appears to be support for tapping the resources of private firms and research institutions worldwide.

The new projects (see accompanying chart) cover such fields as information technology, flexible manufacturing systems and robotics, traffic control, lasers and environmental research. The program, which has a budget of nearly 4 billion ECU ($4.56 billion), encompasses work by more than 600 companies and institutions, an increasing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies